Recently, scientists reported a remarkable finding regarding the membrane expression of somatostatin receptor subtype 2 (SSTR2) in neuroendocrine tumor cells, which is increased approximately 20-fold compared to normal cells. This evidence concerns the gene SSTR2 and neuroendocrine neoplasm.